| Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the Original HDE to get an up-to-date view of this device. |
| |
| Trade Name | OP-1 IMPLANT |
| Classification Name | filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction |
| Generic Name | filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction |
| Applicant |
| Olympus Biotech Corporation |
| 35 s. st. |
| hopkinton, MA 01748 |
|
| HDE Number | H010002 |
| Supplement Number | S031 |
| Date Received | 12/14/2011 |
| Decision Date | 12/27/2011 |
| Product Code | |
| Advisory Committee |
Orthopedic |
| Supplement Type | normal 75 day track |
| Supplement Reason | labeling change - indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | Yes |
Approval Order Statement Approval for modifications to the package insert and an update to the risk analysis to include additional risks associated with antibody cross-reactivity. Op-1implant is indicated for use as an alternative to autograft in recalcitrant long bone nonunions where use of autograft is unfeasible and alternative treatments have failed. Op-i putty is indicated for the repair of symptomatic, posterolateral (intertransverse) lumbar spine pseudoarthrosis in patients for whom autologous bone and/or bone marrow harvest are not feasible or are not expected to promote fusion and who have at least one of the following compromising factors: osteoporosis, diabetes or nicotine use. |
|
|